Economic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 Diabetes in Canada

Conclusions:
From efficiency (cost-effectiveness) and affordability (budget impact) payer perspectives, investing in devices with improved accuracy (less error) appears to be an efficient and affordable strategy.

Source: Journal of Diabetes Science and Technology - March 1, 2016 Category: Endocrinology Authors: McQueen, R. B., Breton, M. D., Ott, M., Koa, H., Beamer, B., Campbell, J. D. Tags: Original Articles Source Type: research